Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Engage Grants Program

University of Western Ontario

$25,000.00

Development and evaluation of tissue-specific bioinks for 3-D printing of meniscus**********

FY 2018-19

Summary
This project will establish a new collaboration between Aspect Biosystems, a Canadian biotechnology company specializing in 3-D bioprinting, and the Flynn lab at Western University, to advance Aspect's development of 3-D printed (3DP) engineered meniscus tissues as an innovative personalized medicine approach for the treatment of meniscal injuries. Building on the Flynn lab's expertise in the design of soft tissue-engineering strategies harnessing the pro-regenerative functionality of naturally-derived biomaterials, the main focus of this Engage project will be on the development of novel tissue-specific bioink formulations tuned to the unique composition of the meniscus that can be used to 3DP customized constructs that mimic the complex 3-D geometry of the human meniscus with high fidelity. This project addresses the critical need for new bioinks designed specifically for this application that can provide the biological cues required to support long-term cell survival and tissue integration in addition to enabling the printing of cell-seeded constructs with well-defined scaffold architectures. The developed bioinks will be tested using Aspect's proprietary 3-D printing platform, and their cell-supportive and pro-regenerative capacities will be probed in cell culture models using adult stem cells derived from fat as a potential therapeutic cell source. The long-term goals are to translate the bioink technologies to be of economic benefit to Canada and to apply the tissue-engineered meniscus constructs to advance towards more effective therapies to improve the quality of life of Canadians. This project will also provide unique training opportunities for highly qualified personnel in the Flynn lab, helping them to develop valuable skills for future careers in the biotechnology sector.*
Program
Engage Grants Program
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
537360-2018
Name nom
Flynn, Lauren
Department département
Chemical and Biochemical Engineering
Organization id
36
Institution établissement
University of Western Ontario
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2018
Competition year année de concours
2018
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1553
Committee name en
Ontario Internal Decision Committee
Committee name fr
Comité de décision interne pour l'Ontario
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1900
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical engineering
Research subject fr
Génie biomédical
Partie
1
Nb partie
1
Application title
Development and evaluation of tissue-specific bioinks for 3-D printing of meniscus**********
Keyword
NSERC
Application summary
This project will establish a new collaboration between Aspect Biosystems, a Canadian biotechnology company specializing in 3-D bioprinting, and the Flynn lab at Western University, to advance Aspect's development of 3-D printed (3DP) engineered meniscus tissues as an innovative personalized medicine approach for the treatment of meniscal injuries. Building on the Flynn lab's expertise in the design of soft tissue-engineering strategies harnessing the pro-regenerative functionality of naturally-derived biomaterials, the main focus of this Engage project will be on the development of novel tissue-specific bioink formulations tuned to the unique composition of the meniscus that can be used to 3DP customized constructs that mimic the complex 3-D geometry of the human meniscus with high fidelity. This project addresses the critical need for new bioinks designed specifically for this application that can provide the biological cues required to support long-term cell survival and tissue integration in addition to enabling the printing of cell-seeded constructs with well-defined scaffold architectures. The developed bioinks will be tested using Aspect's proprietary 3-D printing platform, and their cell-supportive and pro-regenerative capacities will be probed in cell culture models using adult stem cells derived from fat as a potential therapeutic cell source. The long-term goals are to translate the bioink technologies to be of economic benefit to Canada and to apply the tissue-engineered meniscus constructs to advance towards more effective therapies to improve the quality of life of Canadians. This project will also provide unique training opportunities for highly qualified personnel in the Flynn lab, helping them to develop valuable skills for future careers in the biotechnology sector.*